Navigation Links
Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
Date:9/14/2011

this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, our ability to successfully integrate Inovio and VGX Pharmaceuticals, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2010, our Form 10-Q for the three months ended June 30, 2011, and other regulatory filings from time to time. There can be no assurance that any product in Ino
'/>"/>
SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
2. Inovio Pharmaceuticals to Present at Investor Conferences
3. Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results
4. Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
5. Inovio Pharmaceuticals Announces Transition of Avtar Dhillon to Non-Executive Chairman of the Board
6. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
7. Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011
8. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
9. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
10. Inovio Pharmaceuticals to Present at Investor Conferences
11. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 28, 2014 The ... diagnostics Market (products, applications, techniques, end users and ... and Forecast, 2013 - 2020," indicates that the ... by 2020 registering a CAGR of 9.8% from ... diagnosis and cost effectiveness over alternative diagnostic techniques ...
(Date:8/28/2014)... , Aug. 28, 2014  Seres Health, ... diseases related to the human microbiome, announced today ... Vice President of R&D and Chief Scientific Officer, ... on Antimicrobial Agents and Chemotherapy (ICAAC). The presentation ... SER-109, a novel mixture of bacterial spores derived ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- Gateway Analytical ... the 9 th Annual Global Pharma Manufacturing ... September 8-9 th . The Global Pharma Manufacturing ... in small molecule and biologic pharmaceutical manufacturing. The ... that today,s manufacturers face, such as the increasing ...
Breaking Medicine Technology:DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... "Dr. Siegal,s Cookie Diet" Were the Top Two AOL ... McCain" Rounded Out the Top 5, MCLEAN, Va., ... of Dr. Siegal,s COOKIE DIET(R),hunger-controlling foods, today announced that ... named Sarah Palin his running mate, "Dr. Siegal,s,Cookie Diet" ...
... Sept. 5 The Florida,Technology, Research and ... Dr. Herbert Weissbach, distinguished,professor and director of ... the Charles E. Schmidt College of Science, ... of the State University Research,Commercialization Assistance Grant ...
Cached Medicine Technology:Sarah Palin, Dr. Siegal's Cookie Diet, and John McCain Top AOL Hot Searches List on August 29th 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3
(Date:8/29/2014)... Botanica Day Spa recently announced the ... menu along with a special introductory offer for the ... uses small glass cups to create a suctioning of ... a comfortable but effective pressure. The cups are then ... engage more tissue. In contrast, traditional massage primarily uses ...
(Date:8/29/2014)... August 29, 2014 Edvance360, a leading ... tools for online teaching, as well as 2011 winner ... or Learning Management System, announced that their CTO, Brian ... in the ALS Ice Bucket Challenge on behalf of ... Sanders, Edvance360 Co-Founder. , “We know that the options ...
(Date:8/29/2014)... Dallas, Texas (PRWEB) August 29, 2014 ... raw data into observable data, which are used ... are used in health and fitness devices to ... in sensing technology can assist in regular patient ... costs and provide improved treatment results. Sensors help ...
(Date:8/29/2014)... 2014: A new ESC journal on cardiovascular pharmacotherapy is ... Oxford University Press. , European Heart Journal ... special launch issue has been produced for ESC Congress ... journal,s website goes live in September. , Editor in ... the number one journal in the field of clinical ...
(Date:8/29/2014)... According to these recent findings, there has been ... cases in the last few years. Medical expert and Herpes ... infections and the symptoms that make it hard for patients ... people aren't aware of the exact symptoms of these ailments, ... increase in the number of cases over the years has ...
Breaking Medicine News(10 mins):Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 2Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 3Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 4Health News:Edvance360 Participates In the ALS Ice Bucket Challenge (#ALSicebucketchallenge) 2Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 2Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 3Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 4Health News:Mobile Health and Fitness Sensor Market Growing at 40.29% CAGR by 2018 Forecasts a New Report at ReportsnReports.com 5Health News:ESC launches journal on CV pharmacotherapy 2Health News:It was reported that the Number on PositiveSingles.dating increased about 20% in 2014 2
... ESA Biosciences, a Magellan,Biosciences company and leader in ... that James P. Whelan has joined the company ... clinical-diagnostics,business. Mr. Whelan comes to ESA from Laboratory ... president of managed care for LabCorp,s,esoteric business. Previously, ...
... Concrete Legislation in America to Protect Long-Term Care ... Residents in Over 30 Years, ... first of its kind in the nation and the most concrete,legislation to ... signed into law by Oklahoma Governor Brad Henry,on Tuesday, June 10 at ...
... Cincinnati Children,s Hospital Medical Center has revealed new clues into ... blood cancers known as mixed lineage leukemias (MLL) and how ... the June 9 issue of Cancer Cell. , "We document ... altered to form a particular type, or lineage, of leukemia ...
... explored the first fork in the developmental road, getting a ... build either an embryo or a placenta. , By manipulating ... that develops from a fertilized egg but is not yet ... McKnight Brain Institute and the Harvard Stem Cell Institute caused ...
... who are morning people function better on tests , , ... who are morning people tend to get better grades ... of North Texas researchers. , They had 824 undergraduate ... sleep habits and daytime functioning, and found that students ...
... Existing Investment in Passive, Proximity Badges; Provides Strong ... ... 9 Duke University Health System is,deploying a new advanced ... information systems access for its,14,000 clinical users while maintaining strong ...
Cached Medicine News:Health News:ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products 2Health News:ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products 3Health News:Nursing Home for Sex Offenders Becomes Law, a First in America 2Health News:Microenvironment a main driver of aggressive multi-lineage leukemia disease type 2Health News:Microenvironment a main driver of aggressive multi-lineage leukemia disease type 3Health News:Microenvironment a main driver of aggressive multi-lineage leukemia disease type 4Health News:Stem cell discovery sheds light on placenta development 2Health News:Stem cell discovery sheds light on placenta development 3Health News:College Night Owls Have Lower Grades 2Health News:Duke University Health System to Implement Clinically Optimized, Advanced Authentication Solution From Sentillion 2Health News:Duke University Health System to Implement Clinically Optimized, Advanced Authentication Solution From Sentillion 3
... quantitative microplate enzyme immunoassay that detects elevated levels ... small amounts of NMP22 protein in the urine. ... elevated in the urine of patients with bladder ... The use of the NMP22 protein has been ...
... cystometry and urethral pressure profilometry. The ... bladder to be filled while cystometry ... the catheter in the bladder for ... is standing or sitting. Supplied sterile ...
... for cystometry and urethral pressure profilometry. ... faster filling of the bladder and ... lumen catheter construction allows the bladder ... performed. Triple lumen catheter construction allows ...
... Compact desktop analyzer for fast point-of-care ... syndrome, deep vein thrombosis and/or pulmonary embolism. ... rooms. , ,When every minute counts, ... determination of troponin T, myoglobin, and D-Dimer ...
Medicine Products: